Researchers conducted a study that compared early treatment with inhaled zanamivir vs oral oseltamivir on the risk for hospitalization or death due to influenza infection.
Researchers conducted a study to assess the pharmacokinetics and effect of dolutegravir-based antiretroviral therapy in combination with dihydroartemisinin/piperaquine in women with HIV infection who were pregnant.
By December 2020, 80 percent of the 59 priority countries had achieved maternal and neonatal tetanus elimination (MNTE).
In this study, researchers evaluated the clinical features of group B streptococcal infections (GBS) in women who were pregnant, as well as neonatal outcomes associated with GBS infection.
Receipt of a COVID-19 mRNA vaccine does not affect the ovarian response or pregnancy rates in in vitro fertilization (IVF) treatment.
Patients with anemia included in the study were less likely to have taken iron, B6, and folate supplements as recommended.
Pregnancy and delivery are associated with an increased risk for catastrophic health expenditures in the delivery year.
Researchers evaluated the placental antibody transfer function between women with and without HIV infection and its relationship with compromised neonatal immunity.
Investigators at the Centers for Disease Control and Prevention evaluated the effect of a novel 4-month regimen for the treatment of drug-susceptible tuberculosis infection.
Researchers conducted a study to assess outcomes among newborns who were prenatally exposed to maternal COVID-19 vaccination.
